Published in Oncotarget on August 09, 2016
Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection. Oncotarget (2016) 0.80
Tumor volume increases the predictive accuracy of prognosis for gastric cancer: A retrospective cohort study of 3409 patients. Oncotarget (2017) 0.75
Comparison of different lymph node staging systems in prognosis of gastric cancer: a bi-institutional study from Hungary. Chin J Cancer Res (2017) 0.75
Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer (2011) 16.97
Cancer statistics in China, 2015. CA Cancer J Clin (2016) 12.92
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res (2004) 6.22
7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol (2010) 5.64
Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg (2012) 2.85
Advanced hepatocellular carcinoma: which staging systems best predict prognosis? J Clin Oncol (2010) 2.81
Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol (2002) 2.01
Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Ann Surg (2012) 1.96
The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy. Ann Surg Oncol (2012) 1.87
Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer. World J Surg (2012) 1.31
Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. J Clin Oncol (2012) 1.09
The evaluation of metastatic lymph node ratio staging system in gastric cancer. Gastric Cancer (2012) 1.08
Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer. Eur J Surg Oncol (2015) 1.07
Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer. Eur J Surg Oncol (2012) 1.06
Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer. Am J Surg (2013) 1.03
Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients. Surg Oncol (2015) 0.94
Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience. J Gastrointest Surg (2013) 0.93
Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer? Onkologie (2010) 0.92
Lymph Node Ratio-based Staging System Outperforms the Seventh AJCC System for Gastric Cancer: Validation Analysis With National Taiwan University Hospital Cancer Registry. Am J Clin Oncol (2017) 0.91
Metastatic lymph node ratio and prognosis of gastric cancer at different pT stages. Hepatogastroenterology (2015) 0.87
Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases. Oncol Lett (2013) 0.87
Superiority of the ratio between negative and positive lymph nodes for predicting the prognosis for patients with gastric cancer. Ann Surg Oncol (2014) 0.85
Does lymph node ratio affect prognosis in gastroesophageal cancer? Am J Surg (2015) 0.81
Evaluating the relation between patients-related factors and dissected lymph node ratio in gastric cancer. Indian J Cancer (2016) 0.79
Ratio of metastatic to examined lymph nodes is a predictor of mortality in locally advanced gastric cancer treated chemo-radiotherapy. Hepatogastroenterology (2014) 0.78
Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget (2015) 0.84
Prognoses in patients with primary gastrointestinal neuroendocrine neoplasms based on the proposed new classification scheme. Asia Pac J Clin Oncol (2017) 0.75